Search

Search Results

• PO:31:168 | Risk factors for cancer in systemic sclerosis, impact on disease phenotype and prognosis, and proposal of machine learning-based personalized screening strategies: insights from an EUSTAR study Antonio Tonutti^1|2, Francesca Motta^1|2, Stefano Erba^1|2, Britta Maurer³, Cristiana Sieiro Santos³, Duygu Temiz Karadag³, Elena Rezus³, Elisabetta Zanatta³, Fabiola Atzeni³, Francesco Benvenuti³, Gabor Kumanovics³, Gabriella Szucs³, Gianluca Moroncini³, Gonçalo Boleto³, Leila Caillault³, Lilian Maria Lopez Nunez³, Masataka Kuwana³, Massimiliano Limonta³, Maurizio Cutolo³, Oliver Distler³, Radim Bevcar³, Roberto Giacomelli³, Rossella De Angelis³, Serena Guiducci³, Stefano Stano³, Valeria Riccieri³, Yasser El Miedany³, Sophie Blaise³, Carlo Selmi^1|2, Maria De Santis^1|2 | ¹Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; ²Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; ³EUSTAR collaborators EUSTAR * OTHER

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2367

  15

• PO:32:178 | Effectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study Nicola Farina¹, Silvia Bellando-Randone¹, Hilde Jenssen-Bjørkekjær², David Launay³, Patricia Carreira⁴, Paolo Airò⁵, Serena Guiducci¹, Dilia Giuggioli⁶, Gabriela Riemekasten⁷, Carmen-Pilar Simeón Aznar⁸, Christina Bergmann⁹, Elise Siegart¹⁰, Ivan Castellví¹¹, Lesley Ann Saketkoo¹², Jeska De Vries-Bouwstra¹³, Philipp Klemm¹⁴, Ulf Müller-Ladner¹⁴, Alexandra Balbir-Gurman¹⁵, Vanessa Smith¹⁶, Florenzo Iannone¹⁷, Luca Idolazzi¹⁸, Christopher Denton¹⁹, Edoardo Rosato²⁰, Britta Maurer¹, Yannick Allanore¹, Yoshiya Tanaka¹, Elisabetta Zanatta¹, Oliver Distler¹, Marco Matucci-Cerinic¹, Cosimo Bruni¹ | ¹Department of Experimental and Clinical Medicine, Scleroderma Unit, Division of Rheumatology, University of Florence, Az Firenze, Italy; ²Department of Rheumatology, Hospital of Southern Norway Kristiansand, Norway; ³National Reference Center for Pulmonary Arterial Hypertension Pulmotension Lille, France; ⁴Hospital Universitario 12 de Octubre, Rheumatology Department Madrid Spain; ⁵ASST Spedali Civili of Brescia, University of Brescia, Rheumatology and Clinical Immunology Unit Brescia, Italy; ⁶Scleroderma Unit, Rheumatology Unit, University Hospital of Modena and Reggio Emilia Modena, Italy; ⁷Universitätsklinikum Schleswig-Holstein, Klinik für Rheumatologie und klinische Immunologie Lübeck Germany; ⁸Hospital Universitario Vall d'Hebron, Department of Internal Medicine, Systemic Autoimmune Diseases Unit Barcelona Spain; ⁹University Hospital Erlangen, Department Internal Medicine 3 Erlangen Germany; ¹⁰Charité University Hospital, Department of Rheumatology Berlin Germany; ¹¹Hospital de la Santa Creu i Sant Pau Baercelona Spain; ¹²New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center New Orleans, USA; ¹³Leiden University Medical Center, Department of Rheumatology Leiden, The Netherlands; ¹⁴JLU Giessen, Campus Kerckhoff, Department of Rheumatology and Clinical Immunology Center Bad Nauheim Germany; ¹⁵Rambam Health Care Campus, Rheumatology Institute Haifa, Israel; ¹⁶University of Ghent, Department of Rheumatology Ghent, Belgium; ¹⁷Rheumatology DiMePReJ, University of Bari, School of Medicine Bari, Italy; ¹⁸University of Verona, Section of Rheumatology, Department of Medicine Verona, Italy; ¹⁹Royal Free London and University College London Medical School, Centre for Rheumatology London, United Kingdom; ²⁰Sapienza University of Rome, Department of Translational and Precision Medicine Azienda Ospedaliero-Universitaria Policl Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2370

  11

• PO:32:182 | Disease characteristics of anti-centromere positive systemic sclerosis patients and risk factors for organ involvement: data from the EUSTAR cohort Corrado Campochiaro¹, Jelena Colic², Del Papa Nicoletta³, Oliver Distler⁴, Serena Guiducci⁵, Florenzo Iannone⁶, David Launay⁷, Yair Levy⁸, Britta Maurer⁹, Arsene Mekinian¹⁰, Predrag Ostojic², Gabriela Riemekasten¹¹, Petros Sfikakis¹², Bojana Stamenkov¹³, Ulrich Walker¹⁴, Marie Elise Truchetet¹⁵, Madelon Vonk¹⁶, Francesco Del Galdo¹⁷, Giacomo De Luca¹, Lorenzo Dagna¹, Marco Matucci Cerinic¹, Yannick Allanore¹⁸ | ¹IRCCS San Raffaele Hospital; Vita Salute San Raffaele University Milan, Italy; ²University of Belgrade Belgrade, Serbia; ³UOC Reumatologia Clinica, ASST G. Pini CTO Milan, Italy; ⁴University Hospital Zurich Zurich, Switzerland; ⁵Department of Rheumatology, University of Florence Florence, Italy; ⁶Rheumatology Unit Bari, Italy; ⁷CHU Lille Lille, France; ⁸Department of Medicine Kfar Saba, Israel; ⁹Department for BioMedical Research, University of Bern Bern, Switzerland; ¹⁰Service de medecine interne Paris, France; ¹¹Department of Rheumatology University of Lubeck Lubeck Germany; ¹²National and Kapodistrian University of Athens Athens, Greece; ¹³University School of Medicine, Nis Nis, Serbia; ¹⁴University Hospital Basel, Basel Basel, Switzerland; ¹⁵Bordeaux Hospital and University Bordeaux, France; ¹⁶Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; ¹⁷Leeds Institute of Rheumatic and Muskuloskeletal Medicine Leeds, United Kingdom; ¹⁸Cochin Hospital Paris, France

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2372

  13